TY - JOUR
T1 - Tranexamic acid-encapsulating thermosensitive liposomes for site-specific pharmaco-laser therapy of port wine stains
AU - Van Raath, M. Ingmar
AU - Weijer, Ruud
AU - Nguyen, Gia Hung
AU - Choi, Bernard
AU - De Kroon, Anton I.
AU - Heger, Michal
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Site-specific pharmaco-laser therapy (SSPLT) is a developmental stage treatment modality designed to non-invasively remove superficial vascular pathologies such as port wine stains (PWS) by combining conventional laser therapy with the prior administration of a prothrombotic and/or antifibrinolytic pharmaceutical-containing drug delivery system. For the Delivered by Ingenta to: Elsevier BV antifibrinolytic SSPLT component, IP: six 203.56.241.128 different PEGylated On: thermosensitive Tue, 06 Sep 2016 liposomal 15:26:10 formulations encapsulating tranexamic acid (TA), a potent antifibrinolytic
AB - Site-specific pharmaco-laser therapy (SSPLT) is a developmental stage treatment modality designed to non-invasively remove superficial vascular pathologies such as port wine stains (PWS) by combining conventional laser therapy with the prior administration of a prothrombotic and/or antifibrinolytic pharmaceutical-containing drug delivery system. For the Delivered by Ingenta to: Elsevier BV antifibrinolytic SSPLT component, IP: six 203.56.241.128 different PEGylated On: thermosensitive Tue, 06 Sep 2016 liposomal 15:26:10 formulations encapsulating tranexamic acid (TA), a potent antifibrinolytic
KW - Drug delivery system
KW - Fibrinolysis
KW - Fluorescamine derivatization
KW - Heat-Induced release
KW - Thermosensitive liposomes
UR - http://www.scopus.com/inward/record.url?scp=84986563136&partnerID=8YFLogxK
U2 - 10.1166/jbn.2016.2277
DO - 10.1166/jbn.2016.2277
M3 - Article
AN - SCOPUS:84986563136
SN - 1550-7033
VL - 12
SP - 1617
EP - 1640
JO - Journal of Biomedical Nanotechnology
JF - Journal of Biomedical Nanotechnology
IS - 8
ER -